Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

450
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
450
Ligand Binding Sites02:40

Ligand Binding Sites

12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.6K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.6K
Conserved Binding Sites01:49

Conserved Binding Sites

4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flagellar Motor Dynamics of <i>E. coli</i> Persisters under High-Load Reveal Impaired Performance and a Divergent Nonequilibrium State.

The journal of physical chemistry. B·2026
Same author

Computational design of class II MHC binding peptide with sequence-based evolution information.

Bioinformatics advances·2026
Same author

AI-Driven Design of Miniproteins as Potential Allosteric Modulators.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Allosteric regulation of enzymatic catalysis by molecular crowding.

Communications chemistry·2026
Same author

Global Quantitative Dynamics and Early Warning Signals of Hepatocellular Carcinoma: Integrating Theoretical Modeling with Experimental Validation.

The journal of physical chemistry. B·2026
Same author

Driven-Dissipative Quantum Battery with Non-equilibrium Reservoirs.

The journal of physical chemistry letters·2025

Related Experiment Video

Updated: May 14, 2025

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

4.9K

Binding Specificity and Local Frustration in Structure-based Drug Discovery.

Zhiqiang Yan1,2, Yuqing Li2,3, Ying Cao1,2

  • 1Joint Research Centre on Medicine, the Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, Zhejiang, China.

Current Medicinal Chemistry
|May 13, 2025
PubMed
Summary

Understanding protein frustration is key for drug discovery. This review explores quantifying binding specificity and local frustrations to improve drug development, potentially with AI integration.

Keywords:
Energy landscapebinding sitebinding specificitybiomolecular recognitioncryptic site.drug screeninglocal frustration

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Related Experiment Videos

Last Updated: May 14, 2025

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

4.9K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Area of Science:

  • Biochemistry and Structural Biology
  • Computational Chemistry
  • Drug Discovery

Background:

  • Proteins evolve to balance stability and function, creating flexible and frustrated regions on their surfaces.
  • These frustrated regions are crucial for protein function, including ligand binding and conformational changes.
  • Current structure-based drug discovery often prioritizes binding affinity over binding specificity, leading to potential off-target effects.

Purpose of the Study:

  • To explore computational methods for quantifying binding specificity and local protein frustrations.
  • To discuss the application of these methods in structure-based drug discovery.
  • To highlight the potential of integrating artificial intelligence (AI) with these approaches for enhanced drug development.

Main Methods:

  • Review of existing literature on energy landscape theory and protein frustration.
  • Analysis of computational strategies for quantifying binding specificity and local frustrations.
  • Discussion of AI-driven approaches in protein science and drug discovery.

Main Results:

  • Identifying local frustrations offers a promising avenue for screening more specific drug compounds.
  • Quantifying binding specificity complements traditional affinity-focused drug discovery strategies.
  • AI integration holds the potential to accelerate drug discovery and improve hit compound success rates.

Conclusions:

  • Computational quantification of binding specificity and local frustrations is crucial for effective drug discovery.
  • Integrating AI with these methods can significantly enhance the efficiency and success of developing new therapeutics.
  • Future AI-powered models are expected to revolutionize the drug discovery pipeline by improving specificity and reducing off-target effects.